Comparative clinical study to evaluated the antinociceptive efficacy of intravenous versus intraperitoneal dexmedetomidine with ropivacaine in patients undergoing laproscopic cholecystectomy

Comparative clinical study to evaluate the antinociceptive efficacy of intravenous versus intraperitoneal dexmedetomidine with ropivacaine in patients undergoing laproscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033442

Enrollment

Registered

2021-05-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous dexmedetomidine injection in patients undergoing laproscopic cholecystectomy plus 0.25 percent ropivacaine 30 ml port infiltration before closure: Inj dexmedetomedione 0.7

Eligibility

Inclusion criteria

Inclusion criteria: Patient of 18-60 years of ASA grade 1/2

Exclusion criteria

Exclusion criteria: Patient with know allergy to drug if study Pregnancy Patient with drain Patient with hepatic renal cardiac disease Patient on anti hypertensive medications Neurological or psychiatric disease

Design outcomes

Primary

Measure	Time frame
Measure duration of total analgesia Time to first dose of analgesic required post op Total tramadol consumption in 24 hoursTimepoint: Measure duration of total analgesia Time to first dose of analgesic required post op Total tramadol consumption in 24 hours	—

Secondary

Measure	Time frame
Intensity and severity of sedation Hemodynamic change Any side effectTimepoint: 15 may 2021	—

Countries

India

Contacts

Public ContactDr Arvind khare

Jln medical college ajmer

jyotimeena2000@gmail.com8368692389

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026